Rossari Biotech Limited (ROSSARI) Fair Value & Analysis
Basic Materials · IN · Market cap ₹29.0B
Fair value as of: Jul 3, 2026
From 16 valuation models · updated today
Share price −1.2% over the past month.
Price vs Fair Value (12 months)
12‑month range ₹378.60 – ₹743.30 · fair‑value band ₹343.46 – ₹747.35 · the ₹521.65 price screens above the ₹457.94 fair value. As of Jul 3, 2026.
✦ Which stocks are undervalued right now? Check free Discover now →Analysis
Rossari Biotech Limited (ROSSARI) currently trades at ₹521.65, while our model-based Fair Value estimate is ₹457.94 — implying the stock looks roughly 12.2% overvalued today. We read business quality at 46/100 (below-average quality), in the Basic Materials sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: high).
Over the trailing twelve months, Rossari Biotech Limited generated revenue of ₹24.0B at a net margin of 6.2%. Revenue grew 18.2% year over year. It earns a return on equity of 11.9%. Net debt stands at ₹3.4B. Fundamentals as of Jul 3, 2026
Key figures & financial health
More key figures
Figures from reported company fundamentals (EODHD) · as of Jul 3, 2026. TTM = trailing twelve months.
About the company
Rossari Biotech Limited manufactures and sells specialty chemicals in India and internationally. It offers soap and detergents; inks, paints, and coatings; ceramics and tiles; pulp and papers; cement; performance additives; and water treatment solutions. The company also provides textile specialty chemicals, such as cotton, polyester, acrylic, wool, silk, nylon, functional finishes, denim, printing, and sustainable solutions; and pet grooming products, which include natural pet shampoos, powders, deodorants, sprays, creams, and floor washing liquids under the Lozalo, Hunger Fills, and Sniffy brand names. In addition, it offers poultry nutrition products comprising vitamin-mineral formulations, toxin binders, individual and cocktail enzymes, liquid nutraceuticals, and supplements or herbal preparations. The company was formerly known as Rossari Labtech and changed its name to Rossari Biotech Limited in December 2003. Rossari Biotech Limited was founded in 1997 and is based in …
Revenue & earnings trend
FY2022 – FY2026 · reported fiscal years
Rossari Biotech Limited reported revenue of ₹24.0B in FY2026 versus ₹14.8B in FY2022, a compound +12.7%/yr. Reported net income was ₹1.5B in FY2026, compounding +11.2%/yr from FY2022.
Is ROSSARI fairly valued? → Check now
Similar stocks
6 more Specialty Chemicals stocks, each showing price versus our Fair Value estimate (as of Jul 3, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| Linde plc LIN | $509.16 | $159.69 | -69% |
| L'Air Liquide S.A AIQUY | $37.93 | $15.46 | -59% |
| Air Products and Chemicals, Inc A1PD34 | R$360.05 | R$108.63 | -70% |
| Intercontinental Exchange, Inc I1CE34 | R$334.47 | R$67.12 | -80% |
| Wanhua Chemical Group 600309 | ¥74.30 | ¥68.03 | -8% |
| Asian Paints Limited ASIANPAINT | ₹2,715 | ₹655.71 | -76% |
Explore undervalued stocks
More undervalued Basic Materials stocks →
Frequently asked questions
Is Rossari Biotech Limited (ROSSARI) undervalued?
What is the fair value of ROSSARI?
What is the quality score of ROSSARI?
What is the revenue of Rossari Biotech Limited (ROSSARI)?
What is the net profit margin of ROSSARI?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.